At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹Î¨TP).
Since addressing the COVID-19 pandemic, mRNA vaccines have risen as a promising tool for treating a broad range of diseases, such as cancer and genetic disorders. To be effective, foreign mRNA in ...
A pizza shop with 30 delivery people ought to be able to deliver a lot of pizzas - if their cars don't break down on the way. Likewise, genes that produce a lot of messenger RNA (mRNA) molecules can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback